International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

K. M. Giacomini, P. V. Balimane, S. K. Cho, M. Eadon, T. Edeki, K. M. Hillgren, S-M Huang, Y. Sugiyama, D. Weitz, Y. Wen, C. Q. Xia, S. W. Yee, H. Zimdahl, Mikko Niemi, Int Transporter Consortium

Research output: Contribution to journalArticleScientific

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume94
Issue number1
Pages (from-to)23-26
Number of pages4
ISSN0009-9236
DOIs
Publication statusPublished - Jul 2013
MoE publication typeB1 Journal article

Fields of Science

  • MARKEDLY AFFECTS
  • PHARMACOKINETICS
  • ROSUVASTATIN
  • VARIANTS
  • 317 Pharmacy

Cite this

Giacomini, K. M., Balimane, P. V., Cho, S. K., Eadon, M., Edeki, T., Hillgren, K. M., ... Int Transporter Consortium (2013). International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms. Clinical Pharmacology and Therapeutics, 94(1), 23-26. https://doi.org/10.1038/clpt.2013.12
Giacomini, K. M. ; Balimane, P. V. ; Cho, S. K. ; Eadon, M. ; Edeki, T. ; Hillgren, K. M. ; Huang, S-M ; Sugiyama, Y. ; Weitz, D. ; Wen, Y. ; Xia, C. Q. ; Yee, S. W. ; Zimdahl, H. ; Niemi, Mikko ; Int Transporter Consortium. / International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms. In: Clinical Pharmacology and Therapeutics. 2013 ; Vol. 94, No. 1. pp. 23-26.
@article{183ae19b5c4345eeaa3d06ad169f3e54,
title = "International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms",
keywords = "MARKEDLY AFFECTS, PHARMACOKINETICS, ROSUVASTATIN, VARIANTS, 317 Pharmacy",
author = "Giacomini, {K. M.} and Balimane, {P. V.} and Cho, {S. K.} and M. Eadon and T. Edeki and Hillgren, {K. M.} and S-M Huang and Y. Sugiyama and D. Weitz and Y. Wen and Xia, {C. Q.} and Yee, {S. W.} and H. Zimdahl and Mikko Niemi and {Int Transporter Consortium}",
year = "2013",
month = "7",
doi = "10.1038/clpt.2013.12",
language = "English",
volume = "94",
pages = "23--26",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley",
number = "1",

}

Giacomini, KM, Balimane, PV, Cho, SK, Eadon, M, Edeki, T, Hillgren, KM, Huang, S-M, Sugiyama, Y, Weitz, D, Wen, Y, Xia, CQ, Yee, SW, Zimdahl, H, Niemi, M & Int Transporter Consortium 2013, 'International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms', Clinical Pharmacology and Therapeutics, vol. 94, no. 1, pp. 23-26. https://doi.org/10.1038/clpt.2013.12

International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms. / Giacomini, K. M.; Balimane, P. V.; Cho, S. K.; Eadon, M.; Edeki, T.; Hillgren, K. M.; Huang, S-M; Sugiyama, Y.; Weitz, D.; Wen, Y.; Xia, C. Q.; Yee, S. W.; Zimdahl, H.; Niemi, Mikko; Int Transporter Consortium.

In: Clinical Pharmacology and Therapeutics, Vol. 94, No. 1, 07.2013, p. 23-26.

Research output: Contribution to journalArticleScientific

TY - JOUR

T1 - International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

AU - Giacomini, K. M.

AU - Balimane, P. V.

AU - Cho, S. K.

AU - Eadon, M.

AU - Edeki, T.

AU - Hillgren, K. M.

AU - Huang, S-M

AU - Sugiyama, Y.

AU - Weitz, D.

AU - Wen, Y.

AU - Xia, C. Q.

AU - Yee, S. W.

AU - Zimdahl, H.

AU - Niemi, Mikko

AU - Int Transporter Consortium

PY - 2013/7

Y1 - 2013/7

KW - MARKEDLY AFFECTS

KW - PHARMACOKINETICS

KW - ROSUVASTATIN

KW - VARIANTS

KW - 317 Pharmacy

U2 - 10.1038/clpt.2013.12

DO - 10.1038/clpt.2013.12

M3 - Article

VL - 94

SP - 23

EP - 26

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -